Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1993 1
1995 1
1996 2
1997 3
1998 3
2000 3
2001 2
2002 7
2003 3
2004 4
2005 3
2006 7
2007 5
2008 6
2009 12
2010 5
2011 6
2012 2
2013 8
2014 6
2015 11
2016 14
2017 7
2018 9
2019 4
2020 12
2021 15
2022 3
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic potential in rheumatic diseases of extracellular vesicles derived from mesenchymal stromal cells.
Bertolino GM, Maumus M, Jorgensen C, Noël D. Bertolino GM, et al. Among authors: noel d. Nat Rev Rheumatol. 2023 Nov;19(11):682-694. doi: 10.1038/s41584-023-01010-7. Epub 2023 Sep 4. Nat Rev Rheumatol. 2023. PMID: 37666995 Review.
The incidence of rheumatic diseases such as rheumatoid arthritis and osteoarthritis and injuries to articular cartilage that lead to osteochondral defects is predicted to rise as a result of population ageing and the increase in high-intensity physical activities am …
The incidence of rheumatic diseases such as rheumatoid arthritis and osteoarthritis and injuries to articular cartilage that l …
Reply.
Maria AT, Jorgensen C, Le Quellec A, Noël D, Guilpain P. Maria AT, et al. Among authors: noel d. Arthritis Rheumatol. 2016 Sep;68(9):2348-50. doi: 10.1002/art.39756. Arthritis Rheumatol. 2016. PMID: 27214595 No abstract available.
Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?
Bouffi C, Djouad F, Mathieu M, Noël D, Jorgensen C. Bouffi C, et al. Among authors: noel d. Rheumatology (Oxford). 2009 Oct;48(10):1185-9. doi: 10.1093/rheumatology/kep162. Epub 2009 Jun 26. Rheumatology (Oxford). 2009. PMID: 19561159 Review.
Multipotent mesenchymal stromal cells (MSCs) have raised interest mainly because of cartilage/bone differentiation potential which is now partly eclipsed by their capacity to counteract inflammation and suppress host immune responses as well as to prevent fibrosis. ...They …
Multipotent mesenchymal stromal cells (MSCs) have raised interest mainly because of cartilage/bone differentiation potential which is …
Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
Luz-Crawford P, Kurte M, Bravo-Alegría J, Contreras R, Nova-Lamperti E, Tejedor G, Noël D, Jorgensen C, Figueroa F, Djouad F, Carrión F. Luz-Crawford P, et al. Among authors: noel d. Stem Cell Res Ther. 2013 Jun 4;4(3):65. doi: 10.1186/scrt216. Stem Cell Res Ther. 2013. PMID: 23734780 Free PMC article.
INTRODUCTION: Mesenchymal stem cells (MSCs) are adult, multipotent, stem cells with immunomodulatory properties. ...
INTRODUCTION: Mesenchymal stem cells (MSCs) are adult, multipotent, stem cells with immunomodulatory properties. ...
Therapeutic application of mesenchymal stem cells in osteoarthritis.
Ruiz M, Cosenza S, Maumus M, Jorgensen C, Noël D. Ruiz M, et al. Among authors: noel d. Expert Opin Biol Ther. 2016;16(1):33-42. doi: 10.1517/14712598.2016.1093108. Epub 2015 Sep 28. Expert Opin Biol Ther. 2016. PMID: 26413975 Review.
INTRODUCTION: Osteoarthritis (OA) is a degenerative disease characterized by cartilage degradation and subchondral bone alterations. This disease represents a global public health problem whose prevalence is rapidly growing with the increasing aging of the population. With …
INTRODUCTION: Osteoarthritis (OA) is a degenerative disease characterized by cartilage degradation and subchondral bone alterations. …
Deregulation and therapeutic potential of microRNAs in arthritic diseases.
Vicente R, Noël D, Pers YM, Apparailly F, Jorgensen C. Vicente R, et al. Among authors: noel d. Nat Rev Rheumatol. 2016 Apr;12(4):211-20. doi: 10.1038/nrrheum.2015.162. Epub 2015 Dec 24. Nat Rev Rheumatol. 2016. PMID: 26698025 Review.
In this context, the main musculoskeletal cell lineages, which are generated from the pool of mesenchymal stromal cells (MSCs), and the immune cells that participate in rheumatic diseases are deregulated. ...The main studies that identify miRNAs as regulators of immune cel …
In this context, the main musculoskeletal cell lineages, which are generated from the pool of mesenchymal stromal cells (MSCs), and t …
[Mesenchymal stem cells and regenerative medicine: future perspectives in osteoarthritis].
Maumus M, Pers YM, Ruiz M, Jorgensen C, Noël D. Maumus M, et al. Among authors: noel d. Med Sci (Paris). 2018 Dec;34(12):1092-1099. doi: 10.1051/medsci/2018294. Epub 2019 Jan 9. Med Sci (Paris). 2018. PMID: 30623767 Free article. Review. French.
A therapy based on MSCs can be justified in osteoarthritis (OA) thanks to their differentiation abilities but mostly, to their paracrine and immunosuppressive properties. ...Depending on the mode of administration and behavior after implantation, they can decrease local in …
A therapy based on MSCs can be justified in osteoarthritis (OA) thanks to their differentiation abilities but mostly, to their paracr …
Extracellular vesicles from mesenchymal stromal cells: Therapeutic perspectives for targeting senescence in osteoarthritis.
Boulestreau J, Maumus M, Jorgensen C, Noël D. Boulestreau J, et al. Among authors: noel d. Adv Drug Deliv Rev. 2021 Aug;175:113836. doi: 10.1016/j.addr.2021.113836. Epub 2021 Jun 22. Adv Drug Deliv Rev. 2021. PMID: 34166759 Review.
Osteoarthritis (OA) is a common age-related disease that correlates with a high number of senescent cells in joint tissues. ...Targeting senescent cells using senolytics or senomorphics has therefore been tested and improvement of OA-associated features has been reported i …
Osteoarthritis (OA) is a common age-related disease that correlates with a high number of senescent cells in joint tissues. ...Target …
Pathogenic or Therapeutic Extracellular Vesicles in Rheumatic Diseases: Role of Mesenchymal Stem Cell-Derived Vesicles.
Cosenza S, Ruiz M, Maumus M, Jorgensen C, Noël D. Cosenza S, et al. Among authors: noel d. Int J Mol Sci. 2017 Apr 22;18(4):889. doi: 10.3390/ijms18040889. Int J Mol Sci. 2017. PMID: 28441721 Free PMC article. Review.
They are involved in many biological processes that regulate tissue homeostasis and physiopathology of diseases. In rheumatic diseases, namely osteoarthritis (OA) and rheumatoid arthritis (RA), EVs have been isolated from synovial fluid and shown to play pathogenic …
They are involved in many biological processes that regulate tissue homeostasis and physiopathology of diseases. In rheumatic diseases, name …
Mesenchymal Stem Cell Derived Extracellular Vesicles in Aging.
Boulestreau J, Maumus M, Rozier P, Jorgensen C, Noël D. Boulestreau J, et al. Among authors: noel d. Front Cell Dev Biol. 2020 Feb 21;8:107. doi: 10.3389/fcell.2020.00107. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32154253 Free PMC article. Review.
Emerging evidence suggests that the changes in the number and composition of extracellular vesicles (EVs) released by senescent cells contribute to the adverse effects of senescence in aging. In addition, age-related alterations in mesenchymal stem/stromal cells (MSCs) hav …
Emerging evidence suggests that the changes in the number and composition of extracellular vesicles (EVs) released by senescent cells contri …
163 results